Source:http://linkedlifedata.com/resource/pubmed/id/21328246
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2011-2-17
|
| pubmed:abstractText |
Antipsychotic (neuroleptic) medication is used extensively to treat people with chronic mental illnesses. Its use, however, is associated with adverse effects, including movement disorders such as tardive dyskinesia (TD) - a problem often seen as repetitive involuntary movements around the mouth and face. Vitamin E has been proposed as a treatment to prevent or decrease TD.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1469-493X
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
CD000209
|
| pubmed:dateRevised |
2011-6-16
|
| pubmed:meshHeading |
pubmed-meshheading:21328246-Antipsychotic Agents,
pubmed-meshheading:21328246-Dyskinesia, Drug-Induced,
pubmed-meshheading:21328246-Humans,
pubmed-meshheading:21328246-Psychotic Disorders,
pubmed-meshheading:21328246-Randomized Controlled Trials as Topic,
pubmed-meshheading:21328246-Schizophrenia,
pubmed-meshheading:21328246-Vitamin E,
pubmed-meshheading:21328246-Vitamins
|
| pubmed:year |
2011
|
| pubmed:articleTitle |
Vitamin E for neuroleptic-induced tardive dyskinesia.
|
| pubmed:affiliation |
Enhance Reviews Ltd, John Eccles House, Robert Robinson Avenue, Oxford Science Park, Oxford, UK, OX4 4GP.
|
| pubmed:publicationType |
Journal Article,
Review,
Meta-Analysis
|